Protara Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.73 | -100% | -2.59 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
0.3035 | 4.83 | -93.71% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
0.3093 | -22.19 | -101.39% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
0.3559 | 68.74 | -99.48% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | -83.28 | -100% |
| ROE |
|
-59.16 | 9.61 | -715.53% |
|
|
| ROA |
|
-51.19 | 0.3443 | -14970.87% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-63.84 | 15.45 | -513.19% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1263 | -3.68 | -96.56% | -0.1262 | +0.0964% |
| Nеt Debt/Ebitda |
|
0.7885 | -3.44 | -122.94% |
|
|
| Debt/Ratio |
|
0.0692 | 0.1986 | -65.13% |
|
|
| Debt/Equity |
|
0 | 1.56 | -100% |
|
|
| Debt/Net Income |
|
-0.1353 | 10.32 | -101.31% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5411 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5411 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
184.68 | -90.94 | -303.08% | ||
| Growth impulse Net Income in 5 years |
|
174.97 | -97.8 | -278.91% | ||
| Growth impulse FCF in 5 years |
|
139.5 | -49.48 | -381.93% | ||
| Growth impulse EPS in 5 years |
|
41.55 | -32.41 | -228.2% |
IP Score
4.4/10
